There is an unmet need of models for early prediction of morbidity and mortality of Coronavirus disease-19 (COVID-19). We aimed to a) identify complement-related genetic variants associated with the clinical outcomes of ICU hospitalization and death, b) develop an artificial neural network (ANN) predicting these outcomes and c) validate whether complement-related variants are associated with an impaired complement phenotype. We prospectively recruited consecutive adult patients of Caucasian origin, hospitalized due to COVID-19. Through targeted next-generation sequencing, we identified variants in complement factor H/CFH, CFB, CFH-related, CFD, CD55, C3, C5, CFI, CD46, thrombomodulin/THBD, and A Disintegrin and Metalloproteinase with Thrombospondin motifs (ADAMTS13). Among 381 variants in 133 patients, we identified 5 critical variants associated with severe COVID-19: rs2547438 (C3), rs2250656 (C3), rs1042580 (THBD), rs800292 (CFH) and rs414628 (CFHR1). Using age, gender and presence or absence of each variant, we developed an ANN predicting morbidity and mortality in 89.47% of the examined population. Furthermore, THBD and C3a levels were significantly increased in severe COVID-19 patients and those harbouring relevant variants. Thus, we reveal for the first time an ANN accurately predicting ICU hospitalization and death in COVID-19 patients, based on genetic variants in complement genes, age and gender. Importantly, we confirm that genetic dysregulation is associated with impaired complement phenotype.

Asteris P.G., Gavriilaki E., Touloumenidou T., Koravou E.-E., Koutra M., Papayanni P., et al. (2022). Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 26(5), 1445-1455 [10.1111/jcmm.17098].

Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks

Cavaleri L.;
2022-03-01

Abstract

There is an unmet need of models for early prediction of morbidity and mortality of Coronavirus disease-19 (COVID-19). We aimed to a) identify complement-related genetic variants associated with the clinical outcomes of ICU hospitalization and death, b) develop an artificial neural network (ANN) predicting these outcomes and c) validate whether complement-related variants are associated with an impaired complement phenotype. We prospectively recruited consecutive adult patients of Caucasian origin, hospitalized due to COVID-19. Through targeted next-generation sequencing, we identified variants in complement factor H/CFH, CFB, CFH-related, CFD, CD55, C3, C5, CFI, CD46, thrombomodulin/THBD, and A Disintegrin and Metalloproteinase with Thrombospondin motifs (ADAMTS13). Among 381 variants in 133 patients, we identified 5 critical variants associated with severe COVID-19: rs2547438 (C3), rs2250656 (C3), rs1042580 (THBD), rs800292 (CFH) and rs414628 (CFHR1). Using age, gender and presence or absence of each variant, we developed an ANN predicting morbidity and mortality in 89.47% of the examined population. Furthermore, THBD and C3a levels were significantly increased in severe COVID-19 patients and those harbouring relevant variants. Thus, we reveal for the first time an ANN accurately predicting ICU hospitalization and death in COVID-19 patients, based on genetic variants in complement genes, age and gender. Importantly, we confirm that genetic dysregulation is associated with impaired complement phenotype.
mar-2022
Settore ICAR/09 - Tecnica Delle Costruzioni
Asteris P.G., Gavriilaki E., Touloumenidou T., Koravou E.-E., Koutra M., Papayanni P., et al. (2022). Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 26(5), 1445-1455 [10.1111/jcmm.17098].
File in questo prodotto:
File Dimensione Formato  
J Cellular Molecular.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 970.2 kB
Formato Adobe PDF
970.2 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/595107
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 43
social impact